Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FRLN | AZN | AMGN | GILD | BMY |
| Company | Freeline Therapeutics Holdings Plc Adss | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 6.49 | 183.93 | 335.01 | 128.90 | 57.65 |
| High | 6.49 | 187.00 | 339.12 | 129.96 | 58.38 |
| Low | 6.48 | 181.73 | 333.55 | 128.00 | 57.28 |
| Latest | 6.48 | 184.56 | 337.97 | 129.02 | 58.06 |
| Change | unch | -2.12 | -1.60 | -0.24 | -0.20 |
| % Change | unch | -1.14% | -0.47% | -0.19% | -0.34% |
| Volume | 5,600 | 2,236,891 | 1,297,909 | 2,240,399 | 3,421,990 |
| 20-Day Average Volume | 9,370 | 1,903,069 | 2,339,784 | 5,102,020 | 8,599,781 |
| Previous Close | 6.48 | 186.68 | 339.57 | 129.26 | 58.26 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 6.43 | 198.31 | 347.23 | 136.44 | 58.89 |
| 20-Day Raw Stochastic | 92.31% | 10.68% | 12.95% | 6.95% | 15.08% |
| 20-Day Relative Strength | 59.63 | 38.47 | 39.94 | 35.51 | 46.77 |
| Weighted Alpha | +4.30 | +23.36 | +17.06 | +18.52 | +19.01 |
| Today's Opinion | 100% Buy | 24% Buy | 8% Buy | 8% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 72% Buy | 40% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 02/09/24 | -5.31% since 04/22/26 | -2.60% since 04/22/26 | -3.16% since 04/22/26 | -1.40% since 04/22/26 |
| Low | 6.40 on 02/12/24 | 181.74 on 04/29/26 | 333.58 on 04/29/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 6.49 on 02/16/24 | 196.64 on 04/23/26 | 350.69 on 04/23/26 | 134.68 on 04/23/26 | 59.25 on 04/23/26 |
| 1-Month | |||||
| %Chg | +1.09% since 01/16/24 | -2.10% since 03/27/26 | -3.39% since 03/27/26 | -4.13% since 03/27/26 | -0.97% since 03/27/26 |
| Low | 6.36 on 01/24/24 | 181.74 on 04/29/26 | 333.58 on 04/29/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 6.49 on 02/16/24 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +37.58% since 11/16/23 | -0.38% since 01/29/26 | -1.75% since 01/29/26 | -7.77% since 01/29/26 | +6.81% since 01/29/26 |
| Low | 4.63 on 11/17/23 | 181.74 on 04/29/26 | 333.58 on 04/29/26 | 127.64 on 04/27/26 | 54.33 on 01/30/26 |
| High | 6.55 on 12/05/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +65.73% since 08/16/23 | +12.17% since 10/29/25 | +15.48% since 10/29/25 | +8.61% since 10/29/25 | +36.09% since 10/29/25 |
| Low | 2.60 on 10/06/23 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 43.19 on 10/30/25 |
| High | 7.70 on 11/03/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 28,129 | 289,523,488 | 183,260,832 | 160,440,352 | 118,951,480 |
| Shares Outstanding, K | 4,341 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -88,970,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 10,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -12,090,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.66 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 12/01/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Earnings Date | 04/02/24 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.47 | 15.57 | 15.67 | 9.40 |